Phil Kuhn, Isto Biologics’ Chief Commercial Officer, presented at the annual Canaccord Genuity Musculoskeletal Conference where he shared recent milestones for Isto and plans for projected growth. Mr. Kuhn was […]Read More
ST. LOUIS (OCT. 25, 2016) – Isto Biologics is wasting no time in showcasing its bone-regeneration technologies and cell-based therapy to industry leaders and spine surgeons. Isto Biologics, resulting from […]Read More
ST. LOUIS (June 3, 2016) – Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis with $1.5 billion of assets under management, announced today that it […]Read More
ISTO Technologies Sponsors the Pediatric Orthopedic Project’s 5th Medical Mission Trip to the Dominican Republic
ISTO Technologies, Inc., a privately-held orthobiologic regenerative medicine company, is honored to support the mission of the Pediatric Orthopedic Project (POP) to treat needy children in the Dominican Republic. The […]Read More
Visit ISTO at Booth #1271 during the North American Spine Society Annual Meeting in Chicago, October 14-16th. Learn more about our newest product, CellPoint Concentrated Bone Marrow Aspirate System, and […]Read More
ISTO to exhibit at the North American Spine Society (NASS) Annual Meeting featuring its newest product, CellPoint™ Concentrated Bone Marrow Aspirate System.
ISTO Technologies will feature its newest product, CellPoint Concentrated Bone Marrow Aspirate System, at the NASS 2015 Annual Meeting in Chicago.Read More